GE HealthCare (GEHC): Buy, Sell, or Hold Post Q2 Earnings?

Over the last six months, GE HealthCare’s shares have sunk to $68.00, producing a disappointing 7.9% loss - a stark contrast to the S&P 500’s 13.5% gain. This may have investors wondering how to approach the situation.